Switching Strategy in the Management of Patients with Pulmonary Arterial Hypertension. The REPLACE Study Results
The article is devoted to topical issues of management of patients with pulmonary arterial hypertension and strategies for switching to riociguat therapy in patients with insufficient clinical response against the background of phosphodiesterase type 5 (PDE-5) inhibitors. The role of the NO metaboli...
Saved in:
| Main Author: | E. V. Filippov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2020-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2342 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TACTICS FEATURES OF CONDUCTING AND CHOOSING SPECIFIC THERAPY FOR ADULT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE
by: O. A. Arkhipova, et al.
Published: (2018-03-01) -
Vericiguat improves cardiac remodelling and function in rats with doxorubicin‐induced cardiomyopathy
by: Wen Chen, et al.
Published: (2025-06-01) -
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models
by: Thomas Sorz-Nechay, et al.
Published: (2025-07-01) -
New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations
by: T. V. Martynyuk, et al.
Published: (2010-04-01) -
PATHOGENETIC MECHANISMS AND TREATMENT PRINCIPLES OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: N. A. Shostak, et al.
Published: (2016-01-01)